Combined serious adverse events of myocardial infarction , stroke and hospitalization for heart failure or cardiovascular death in the atenolol group occurred in 10 subjects , who had 11 events and in the lisinopril group in 17 subjects , who had 23 events ( IRR 2.29 , P = 0.021 ) .